Elanur Karaman

5PUBLICATIONS
54CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|Jan 28, 2026
Prognostic Impact of RAS and TP53 Mutation Profiles in Metastatic Colorectal Cancer.

Mustafa Emre Duygulu, Elanur Karaman, Serdar Karakullukçu

|Aug 28, 2025
Evaluation of PD-L1 Expression and Anti-EGFR Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer.

Gizem Teoman, Elanur Karaman, Şafak Ersöz

|Sep 22, 2022
The effects of thymoquinone on pancreatic cancer and immune cells.

Celal Alandağ, Derya Dilek Kancaği, Gözde Karakuş Sir

|Aug 12, 2022
The Effect of Sarcopenia and Metabolic PET-CT Parameters on Survival in Locally Advanced Non-Small Cell Lung Carcinoma.

Elanur Karaman, Nur Hursoy, Sibel Goksel

Pageof 1

Frequent Collaborators

1 joint publications

Nur Hursoy

1 joint publications

Sibel Goksel

1 joint publications

Celal Alandağ

1 joint publications

Derya Dilek Kancaği